HI-Bio

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Health and bio

TIMELINE · MONEY RAISED

HI-Bio | 189 days from X account to first raise on record

@HIBiosciences·Raised $215M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. January 4, 2024
   Series B+ · $95M
   AAlpha Wave Global (lead), AARCH Venture Partners, AArkin Capital, JJeito Capital, VViking Global Investors
   Source: fundraisingfox.com
2. November 1, 2022
   Series A · $120M
   AARCH Venture Partners (lead), JJeito Capital (lead), MMonograph Capital (lead), MMorphoSys
   Source: vcnewsdaily.com
3. April 26, 2022
   X account created
4. January 28, 1999
   Website created

Founders and team

• TM
  Travis Murdoch Founder

  LinkedIn
• AK
  Ariella Kelman Senior Vice President of Development
• CE
  Carl Enell Chief Business Officer
• JL
  Joyce Liaw Vice President of Finance
• LD
  Lorna Dean Vice President of Clinical Operations
• MA
  Matthew Albert Chief Translational Officer

Investors

• AAlpha Wave Globallead investor
• AARCH Venture Partnerslead investor
• AArkin Capital
• JJeito Capitallead investor
• MMonograph Capitallead investor
• MMorphoSys
• VViking Global Investors

Companies like HI-Bio

• OOuro Medicines$120M Series A · Jan 2025
• MMirador Therapeutics$250M Series B+ · Jan 2026
• FFreya BiosciencesSeries A · Nov 2024
• KKhartis Therapeutics$95M Series B+ · Aug 2026
• EEngimmune Therapeutics$16M Seed · May 2022
• SSudo Bio$37M Series A · Sep 2022

Other companies backed by Alpha Wave Global

• AAdvanCell$315M Series B+ · Jul 2026
• UUltrahuman$60M Series B+ · Jul 2026
• WWealthy$14.5M Series B+ · Nov 2025
• SStanza Living$32.19M Series B+ · Oct 2025
• TTavily (Acquired by Nebius)$25M Series A · Aug 2025
• PPlotX$5M Seed · Jan 2022

Alpha Wave Global portfolio →